Seeking Alpha

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of ...

CARMEL, Ind., Sept. 12, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies that ...
The Globe and Mail

NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines ...

Practice guidelines published in the Journal of Pediatric Gastroenterology & Nutrition (JPGN) name Percutaneous Electrical Nerve Field Stimulation (PENFS) as a recommended treatment option for FAP in ...
The Globe and Mail

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional ...

CARMEL, Ind., May 20, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...